Dissociation between complement activation, integrin expression and neutropenia during hemodialysis.
Complement activation, neutrophil stimulation, increased cellular adhesiveness, transient leukocyte margination and pulmonary leukostasis take place during hemodialysis with cellulosic dialysis membranes. Several investigators have hypothesized that complement activation is primarily responsible for the acute neutropenia occurring during the early phase of bio-incompatible hemodialysis. We have investigated the relationship between complement activation, levels of expression of CD11b and CD61 integrins on neutrophils and platelets, neutrophil counts and blood gas measurements in patients dialyzed with three types of membranes, known to activate the complement system to a different extent. Polysulfone, cellulose acetate and cuprophane membranes were used subsequently in six patients in a prospective cross-over trial design to reduce inter-individual variability. Increased levels of CD61 and CD11b, as well as neutropenia, were detected regardless of the type of membrane used. We observed a high inter-individual variation with regard to complement activation suggesting varying susceptibility to dialysis membranes. We also report that the kinetics of anaphylatoxin generation were dissociated from those of the upregulation of adhesion molecules, early neutrophil margination and decrease in PaO2 during the first 30 min of hemodialysis. Similar results were obtained with all three types of dialysis membranes. The data strengthen the hypothesis that factors other than complement are involved in the induction of dialysis-related neutropenia and hypoxemia.
Rousseau
Y
Y
Institut National de la Santé et de la Recherche Médicale, INSERM U430, Hôpital Broussais, Paris, France.
Carreno
M P
MP
Poignet
J L
JL
Kazatchkine
M D
MD
Haeffner-Cavaillon
N
N
D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use; D001672:Biocompatible Materials; D002482:Cellulose / Q000031:analogs & derivatives; D003167:Complement Activation; D006801:Humans; D016023:Integrins / Q000097:blood*; D007676:Kidney Failure, Chronic / Q000097:blood / Q000276:immunology / Q000628:therapy*; D008567:Membranes, Artificial; D008875:Middle Aged; D009503:Neutropenia / Q000209:etiology*; D006435:Renal Dialysis / Q000009:adverse effects / Q000295:instrumentation*; D013450:Sulfones
D000925:Anticoagulants; D001672:Biocompatible Materials; D016023:Integrins; D008567:Membranes, Artificial; D013450:Sulfones; C005062:acetylcellulose; D002482:Cellulose; C009865:cuprammonium cellulose